Écrit par WHO | 10 Juillet 2019

MBUJI-MAYI / GENEVA, 3 JULY 2019 -- Phase 2 of the biggest ever oral vaccination campaign against cholera is scheduled to take place from 3-8 July 2019 in 15 health districts in the four central provinces of the Democratic Republic of the Congo (DRC) - Kasaï, Kasaï Oriental, Lomami et Sankuru. The second dose of vaccine confers lasting immunity against cholera, and is being targeted at 1...

Écrit par WHO | 10 Juillet 2019

3 July 2019 - On 25 April 2019, the local administration in Larkana district was alerted by media reports of a surge in human immunodeficiency virus (HIV) cases among children in Ratodero Taluka, Larkana district, Sindh province, Pakistan. A screening camp was initially established at Taluka’s main hospital. Later, screening was expanded to other health facilities including selected...

Écrit par Pivotal | 10 Juillet 2019

Madrid, Spain 3 July, 2019 – Pivotal, a specialist CRO, has been awarded two clinical trials for a novel investigational immunotherapy drug and patients' enrolment has now started. Pivotal will use its deep knowledge of oncology drug development to address a critical need for the expansion of immunotherapy programmes for Metastatic Melanoma (MM) and...

Écrit par ANSM | 10 Juillet 2019

Information destinée aux spécialistes en oncologie ou en hématologie, aux médecins compétents en cancérologie ou en maladies du sang, hépatologues, infectiologues, pharmaciens hospitaliers

Des cas de réactivation du virus de l'hépatite B (VHB), dont certains d'issue fatale, ont été rapportés chez des patients traités par Darzalex (daratumumab).

Tous les patients doivent...